Cara Therapeutics, Inc. (Nasdaq: CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Cara Therapeutics (CARA) Prices 5.5M Share Common Offering at $23/ShJuly 25, 2019 5:52 AM Cara Therapeutics Announces Proposed Offering of Common StockJuly 24, 2019 4:02 PM